← FDA DRUG APPROVALS

FDA ANDA · ANDA217608

FOSFOMYCIN TROMETHAMINE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA217608
TYPE
ANDA
ORIGINAL APPROVAL
2025-11-14
LATEST ACTION
2025-11-14
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription

Products

FOSFOMYCIN TROMETHAMINEPrescription
FOSFOMYCIN TROMETHAMINE EQ 3GM BASE/PACKET · FOR SOLUTION · ORAL

Approval history

2025-11-14UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →